XML 40 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Calculation of Basic and Diluted Earnings per Share
6 Months Ended
Jun. 30, 2014
Calculation of Basic and Diluted Earnings per Share[Abstract]  
Calculation of Basic and Diluted Earnings per Share

Note 5.   Calculation of Basic and Diluted Earnings per Share

The following table sets forth the computation of basic and diluted earnings per share:

 

(in thousands, except per share amounts)

 

Three Months
Ended June 30,

 

Six Months
Ended June 30,

 
   

2014

 

2013

 

2014

 

2013

 

Numerator:

                 

Net Income

  $ 153   $ 150   $ 860   $ 75  

Numerator for basic earnings per share - 

income available to common shareholders

    153     150     860     75  

Effect of dilutive securities:

                                 

Numerator for diluted earnings per share - 

income available to common shareholders 

after assumed conversions

  $ 153   $ 150   $ 860   $ 75  
                                   

Denominator:

                                 

Denominator for basic earnings per share - 

weighted-average shares

    3,014     2,998     3,014     2,992  

Effect of dilutive securities:

                                 

Employee stock options

    (5)     (1)     -     -  

Warrants

    393     407     393     204  

Dilutive potential common shares

    388     406     393     204  

Denominator for diluted earnings per share - 

weighted-average shares and assumed conversions

    3,402     3,404     3,407     3,196  

Basic earnings per common share

  $ 0.05   $ 0.05   $ 0.29   $ 0.03  

Diluted earnings per common share

  $ 0.04   $ 0.04   $ 0.25   $ 0.02  

 

 

For the three and six month periods ended June 30, 2014 and 2013, approximately 106,000 and 65,000, respectively, of shares issuable upon exercise of employee stock options were excluded from the calculation of diluted earnings per share as the exercise price was greater than the average market price of the common shares and, therefore, the effect would be anti-dilutive.